{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T12:27:18Z","timestamp":1761395238976,"version":"3.37.3"},"reference-count":19,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0196596","type":"journal-article","created":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T17:38:03Z","timestamp":1525196283000},"page":"e0196596","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":10,"title":["Real life management of patients hospitalized with multiple myeloma in France"],"prefix":"10.1371","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1875-134X","authenticated-orcid":true,"given":"Charles","family":"Dumontet","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandrine","family":"Couray-Targe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marion","family":"Teisseire","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lionel","family":"Karlin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Delphine","family":"Maucort-Boulch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2018,5,1]]},"reference":[{"issue":"1","key":"ref1","doi-asserted-by":"crossref","first-page":"e009584","DOI":"10.1136\/bmjopen-2015-009584","article-title":"Incidence of multiple myeloma in Great Britain, Sweden, and Malmo, Sweden: the impact of differences in case ascertainment on observed incidence trends","volume":"6","author":"R Velez","year":"2016","journal-title":"BMJ Open"},{"issue":"3","key":"ref2","doi-asserted-by":"crossref","first-page":"225","DOI":"10.4065\/mcp.2009.0426","article-title":"Patterns of multiple myeloma during the past 5 decades: stable incidence rates for all age groups in the population but rapidly changing age distribution in the clinic","volume":"85","author":"I Turesson","year":"2010","journal-title":"Mayo Clin Proc"},{"issue":"6","key":"ref3","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.blre.2015.06.001","article-title":"Treatment for patients with newly diagnosed multiple myeloma in 2015","volume":"29","author":"MV Mateos","year":"2015","journal-title":"Blood Rev"},{"issue":"5","key":"ref4","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1038\/leu.2017.60","article-title":"Monoclonal antibody therapy in multiple myeloma","volume":"31","author":"C Touzeau","year":"2017","journal-title":"Leukemia"},{"issue":"5","key":"ref5","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/j.1445-5994.2008.01738.x","article-title":"Safety and efficacy results from an international expanded access programme to bortezomib for patients with relapsed and\/or refractory multiple myeloma: a subset analysis of the Australian and New Zealand data of 111 patients","volume":"39","author":"H Quach","year":"2009","journal-title":"Intern Med J"},{"issue":"4","key":"ref6","doi-asserted-by":"crossref","first-page":"848","DOI":"10.3109\/10428194.2013.806801","article-title":"Real-life patterns of use and effectiveness of bortezomib: the VESUVE cohort study","volume":"55","author":"A Fourrier-Reglat","year":"2014","journal-title":"Leuk Lymphoma"},{"issue":"5","key":"ref7","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.canep.2015.08.002","article-title":"Trends in survival of multiple myeloma: a thirty-year population-based study in a single institution","volume":"39","author":"R Rios-Tamayo","year":"2015","journal-title":"Cancer Epidemiol"},{"issue":"6","key":"ref8","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.revmed.2014.11.009","article-title":"French health insurance databases: What interest for medical research?","volume":"36","author":"G Moulis","year":"2015","journal-title":"Rev Med Interne"},{"issue":"12","key":"ref9","doi-asserted-by":"crossref","first-page":"e6189","DOI":"10.1097\/MD.0000000000006189","article-title":"Identifying multiple myeloma patients using data from the French health insurance databases: Validation using a cancer registry","volume":"96","author":"A Palmaro","year":"2017","journal-title":"Medicine (Baltimore)"},{"issue":"25","key":"ref10","doi-asserted-by":"crossref","first-page":"5501","DOI":"10.1182\/blood-2010-07-298760","article-title":"Racial disparities in incidence and outcome in multiple myeloma: a population-based study","volume":"116","author":"AJ Waxman","year":"2010","journal-title":"Blood"},{"issue":"10","key":"ref11","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1056\/NEJMoa1402551","article-title":"Lenalidomide and dexamethasone in transplant-ineligible patients with myeloma","volume":"371","author":"L Benboubker","year":"2014","journal-title":"N Engl J Med"},{"issue":"6","key":"ref12","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.3109\/10428194.2015.1096354","article-title":"Patterns and effectiveness of bortezomib use according to age in the VESUVE cohort","volume":"57","author":"A Grelaud","year":"2016","journal-title":"Leuk Lymphoma"},{"issue":"2","key":"ref13","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/ejh.12571","article-title":"A cost-effectiveness analysis of real-world treatment for elderly patients with multiple myeloma using a full disease model","volume":"96","author":"HM Blommestein","year":"2015","journal-title":"Eur J Haematol"},{"issue":"6","key":"ref14","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.clml.2012.06.008","article-title":"Assessment of vulnerability measures and their effect on survival in a real-life population of multiple myeloma patients registered at Marche Region Multiple Myeloma Registry","volume":"12","author":"M Offidani","year":"2012","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"5","key":"ref15","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1002\/pds.4180","article-title":"Real-life practices for preventing venous thromboembolism in multiple myeloma patients: a cohort study from the French health insurance database","volume":"26","author":"A Palmaro","year":"2017","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"7","key":"ref16","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1002\/ajh.24389","article-title":"Early mortality in multiple myeloma: the time-dependent impact of comorbidity: A population-based study in 621 real-life patients","volume":"91","author":"R Rios-Tamayo","year":"2016","journal-title":"Am J Hematol"},{"issue":"3","key":"ref17","first-page":"1059","article-title":"Bortezomib, Thalidomide and Lenalidomide: Have They Really Changed the Outcome of Multiple Myeloma?","volume":"36","author":"M Mian","year":"2016","journal-title":"Anticancer Res"},{"issue":"4","key":"ref18","first-page":"844","article-title":"MELISSE, a large multicentric observational study to determine risk factors of venous thromboembolism in patients with multiple myeloma treated with immunomodulatory drugs","volume":"110","author":"X Leleu","year":"2013","journal-title":"Thromb Haemost"},{"issue":"8","key":"ref19","article-title":"The real world effectiveness of hematopoietic transplant among elderly individuals with multiple myeloma","volume":"107","author":"AN Winn","year":"2015","journal-title":"J Natl Cancer Inst"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0196596","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T06:59:13Z","timestamp":1589007553000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0196596"}},"subtitle":[],"editor":[{"given":"Sakamuri V.","family":"Reddy","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2018,5,1]]},"references-count":19,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2018,5,1]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0196596","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2018,5,1]]}}}